Page 17 - Practice Management News Today

At a panel discussion held by the Ontario Medical Association, doctors cited administrative burdens and declining pay and called for immediate reforms.

Reducing out-of-pocket costs in a value-based medication plan may modestly improve short-term health outcomes in commercially insured individuals with diabetes.

Planet DDS, the leading provider of cloud-based dental software solutions, congratulates Park Dental Partners on successfully implementing Denticon practice management solution across Park Dental Partners' affiliated dental groups with over 80...

Fresenius Medical Care's shares fell 5% on Tuesday, despite upbeat quarterly results and higher 2024 guidance, with analysts highlighting a weak outlook for patient volumes...

A partner with Weil, Gotshal & Manges apparently missed an opinion telling his law firm that incorporating an argument by reference can’t be used to exceed word-count limits in briefs, according to the U.S. Court of Appeals for the Federal Circuit.

IMARC Group expects the market to reach US$ 771.9 Million by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.

We’ve all heard the cliches: You only get one chance to make a first impression, dress for success, and you are what you wear. While these maxims are familiar, they are also true. You are judged in less than seven seconds, so dressing appropriately can help you win or lose your case.

Incidence of stroke was significantly higher among Indigenous people in affluent countries than their non-Indigenous counterparts.

Dye & Durham (TSE:DND – Free Report) had its price target trimmed by Scotiabank from C$25.00 to C$24.00 in a research note issued to investors on Wednesday, BayStreet.CA reports. The firm currently has an outperform rating on the stock. Several other brokerages have also weighed in on DND. Cormark lowered their target price on shares […]

Dye & Durham (TSE:DND – Free Report) had its target price hoisted by Raymond James from C$15.00 to C$16.00 in a report released on Wednesday, BayStreet.CA reports. The firm currently has an outperform rating on the stock. Raymond James also issued estimates for Dye & Durham’s FY2024 earnings at ($1.12) EPS and FY2025 earnings at […]